Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile
Huntsman Cancer Institute

@huntsmancancer

The Mountain West’s only NCI-Designated Comprehensive Cancer Center—Delivering a Cancer-Free Frontier™ through innovative research & world-class patient care.

ID: 20004102

linkhttp://huntsmancancer.org calendar_today03-02-2009 21:07:46

15,15K Tweet

12,12K Followers

1,1K Following

Shilpa Gupta (@shilpaonc) 's Twitter Profile Photo

#ASCO2025 Powerful letter from ASCO #DailyNews Editor Neeraj Agarwal, MD, FASCO “In the fight against cancer, we are united by purpose.” Thx for all your hard work & dedication to making this the most valuable free resource for oncology professionals 🌏 by bringing key insights from

#ASCO2025 Powerful letter from <a href="/ASCO/">ASCO</a> #DailyNews Editor <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> 
“In the fight against cancer, we are united by purpose.” Thx for all your hard work &amp; dedication to making this the most valuable free resource for oncology professionals 🌏 by bringing key insights from
Katie Kerrigan, DO (@kkerrigan16) 's Twitter Profile Photo

Practice changing study in anaplastic thyroid cancer! Proud to have contributed to the study. This is an aggressive, rare, and difficult to treat cancer and we are moving the needle! Huge shout out to our clinical trials teams. Mark Zafereo, MD MD Anderson Cancer Center Huntsman Cancer Institute

Practice changing study in anaplastic thyroid cancer! Proud to have contributed to the study. This is an aggressive, rare, and difficult to treat cancer and we are moving the needle! Huge shout out to our clinical trials teams. <a href="/MarkZafereoMD/">Mark Zafereo, MD</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a>
Zeynep Irem Ozay, MD (@ziremozay) 's Twitter Profile Photo

🌟Great presentation by Chadi Hage Chehade at #ASCO25!! Utilization and timing of NGS in pts w/ 5 most common cancers in the US👉Many pts either don’t receive NGS or have the first NGS very late 👇ASCO OncoAlert Neeraj Agarwal, MD, FASCO Umang Swami Flatiron Health UroToday.com

🌟Great presentation by <a href="/chadihcmd/">Chadi Hage Chehade</a> at #ASCO25!!

Utilization and timing of NGS in pts w/ 5 most common cancers in the US👉Many pts either don’t receive NGS or have the first NGS very late 👇<a href="/ASCO/">ASCO</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> <a href="/umangtalking/">Umang Swami</a> <a href="/flatironhealth/">Flatiron Health</a> <a href="/urotoday/">UroToday.com</a>
Nicolas Sayegh, MD (@nsayeghmd) 's Twitter Profile Photo

👉🏻 Our very own Chadi Hage Chehade presenting ASCO a real-world study showing most patients do not undergo NGS testing, and a substantial proportion receive it only near end of life—limiting its clinical utility and impact on treatment decisions. #ASCO25 GU Cancer Research Program @HuntsmanCancer Neeraj Agarwal, MD, FASCO

👉🏻 Our very own <a href="/chadihcmd/">Chadi Hage Chehade</a> presenting <a href="/ASCO/">ASCO</a> a real-world study showing most patients do not undergo NGS testing, and a substantial proportion receive it only near end of life—limiting its clinical utility and impact on treatment decisions. #ASCO25 

<a href="/Huntsman_GU/">GU Cancer Research Program @HuntsmanCancer</a> <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a>
Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

We are honored to serve as the NCI-designated Comprehensive Cancer Center for Idaho. We're grateful to Congressman Mike Simpson for meeting with Neli Ulrich & Brad Cairns to discuss the promise of research & our partnerships across Idaho to reduce the burden of cancer.

We are honored to serve as the NCI-designated Comprehensive Cancer Center for Idaho. We're grateful to <a href="/CongMikeSimpson/">Congressman Mike Simpson</a> for meeting with Neli Ulrich &amp; Brad Cairns to discuss the promise of research &amp; our partnerships across Idaho to reduce the burden of cancer.
UroToday.com (@urotoday) 's Twitter Profile Photo

Real-world quality of life for patients with metastatic #RCC treated with systemic therapy in the prospective observational #ODYSSEY study. Presentation by Benjamin L Maughan Huntsman Cancer Institute. #ASCO25 written coverage by Zach Klaassen > bit.ly/4dGS2WV ASCO

Real-world quality of life for patients with metastatic #RCC treated with systemic therapy in the prospective observational #ODYSSEY study. Presentation by <a href="/maughanonc/">Benjamin L Maughan</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a>. #ASCO25 written coverage by <a href="/zklaassen_md/">Zach Klaassen</a> &gt; bit.ly/4dGS2WV <a href="/ASCO/">ASCO</a>
Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (@tomleblancmd) 's Twitter Profile Photo

Thankful for the opportunity to represent the "V-RULES real-world registry" of patients treated with CPX-351 for AML (t-AML or AML-MRC, per its FDA label) at #ASCO25, on behalf of a great team of investigators across 10 sites! This analysis confirms randomized phase 3 data

Thankful for the opportunity to represent the "V-RULES real-world registry" of patients treated with CPX-351 for AML (t-AML or AML-MRC, per its FDA label) at #ASCO25, on behalf of a great team of investigators across 10 sites! This analysis confirms randomized phase 3 data
UroToday.com (@urotoday) 's Twitter Profile Photo

Mevrometostat in combination with enzalutamide in patients with #mCRPC previously treated with abiraterone acetate: The phase 3, randomized #MEVPRO-1 study. Presentation by Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute. #ASCO25 written coverage by Julian Chavarriaga University of Toronto > bit.ly/3SyaeZi

Mevrometostat in combination with enzalutamide in patients with #mCRPC previously treated with abiraterone acetate: The phase 3, randomized #MEVPRO-1 study. Presentation by <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a>. #ASCO25 written coverage by <a href="/chavarriagaj/">Julian Chavarriaga</a> <a href="/UofT/">University of Toronto</a> &gt; bit.ly/3SyaeZi
Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

Welcome to our 2025 PathMaker Programs Scholars! These bright high school and undergrad students will spend the next 10 weeks immersed in hands-on cancer research. We're excited to see where their curiosity and passion take them.

Welcome to our 2025 <a href="/PathMaker_HCI/">PathMaker Programs</a> Scholars! These bright high school and undergrad students will spend the next 10 weeks immersed in hands-on cancer research. We're excited to see where their curiosity and passion take them.
University of Utah Department of Internal Medicine (@uofuinternalmed) 's Twitter Profile Photo

Join us as we celebrate the retirement of Dr. Wallace Akerley, medical oncologist at Huntsman Cancer Institute and professor of oncology in our department. Learn more: healthcare.utah.edu/huntsmancancer… 🌟

Join us as we celebrate the retirement of Dr. Wallace Akerley, medical oncologist at <a href="/huntsmancancer/">Huntsman Cancer Institute</a> and professor of oncology in our department. Learn more: healthcare.utah.edu/huntsmancancer… 🌟
Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

Thank you Rep. Celeste Maloy for meeting with Neli Ulrich, PhD, & Brad Cairns, PhD, to discuss cancer care across Utah’s 2nd district. As Utah’s NCI-designated center, we’re committed to advancing research-driven care for every Utahn—from urban areas to rural and frontier communities.

Thank you <a href="/RepMaloyUtah/">Rep. Celeste Maloy</a> for meeting with Neli Ulrich, PhD, &amp; Brad Cairns, PhD, to discuss cancer care across Utah’s 2nd district. As Utah’s NCI-designated center, we’re committed to advancing research-driven care for every Utahn—from urban areas to rural and frontier communities.
UofUHeme (@uofuhematology) 's Twitter Profile Photo

Join UofUHeme with Tsewang Tashi MD, Laura Bickel APC and Mili Shum MD on Saturday June 28 for the Patient and Family caregiver conference on Systemic Mastocytosis. Sponsored by TMS, AIM and Medscape. University of Utah Health Huntsman Cancer Institute

Join <a href="/UofUHematology/">UofUHeme</a>
 with Tsewang Tashi MD, Laura Bickel APC and Mili Shum MD on Saturday June 28 for the Patient and Family caregiver conference on Systemic Mastocytosis. Sponsored by TMS, AIM and Medscape. <a href="/UofUHealth/">University of Utah Health</a>
 <a href="/huntsmancancer/">Huntsman Cancer Institute</a>
Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

Congratulations to our affiliate hospital in Wyoming, Memorial Hospital, on receiving this grant! A big win for their team—and even better news for the patients they serve. MHSC: Cancer Center receives $6,000 ACS transportation grant wyo4news.com/news/mhsc-canc… via Wyo4News

Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

Welcome to the 2025 5ForTheFight 🔔 Cancer Research interns from Howard University and Morehouse College. This summer, they’ll conduct hands-on research with faculty mentors, grow through workshops, and explore Utah. We’re proud to support the next generation of cancer researchers.

Welcome to the 2025 <a href="/5ForTheFight_/">5ForTheFight 🔔</a> Cancer Research interns from <a href="/HowardU/">Howard University</a> and <a href="/Morehouse/">Morehouse College</a>. This summer, they’ll conduct hands-on research with faculty mentors, grow through workshops, and explore Utah. We’re proud to support the next generation of cancer researchers.